HMO 51000-USA #SQUADROX-i Small Ad.+Filter /Small Adult. Filter
70106.7895
QUADROX-i Small Adult Microporous membrane oxygenator with integrated arterial f
QUADROX-i Small Adult Microporous membrane oxygenator with integrated arterial filter, SOFTLINE coated, and a screw connector
BEQ-HMO 51000 #SQUADR-i Small Adult +Fi. / Small Adult, Filter; BIOLINE Coating
70106.7911
QUADROX-i Small Adult Microporous Membrane Oxygenator with integrated arterial f
QUADROX-i Small Adult Microporous Membrane Oxygenator with integrated arterial filter, BIOLINE coated, with a screw connector
BEQ-HMO 50000-USA #SQUADR-i Small Ado.Fi / Small Adult, BIOLINE
70106.7905
QUADROX-i Small Adult Microporous Membrane Oxygenator, BIOLINE coated, without f
QUADROX-i Small Adult Microporous Membrane Oxygenator, BIOLINE coated, without filter, with a screw connector
QUADROX-i Small Adult Microporous Membrane Oxygenator, SOFTLINE coated, without
QUADROX-i Small Adult Microporous Membrane Oxygenator, SOFTLINE coated, without filter, with a screw connector
Venous Hardshell Cardiotomy Reservoir, Adult, non-coated, with cardiotomy filter
Venous Hardshell Cardiotomy Reservoir, Adult, non-coated, with cardiotomy filter, without screw connector, Sterile. The Venous Hardshell Cardiotomy Reservoirs are developed for the use in the field cardiopulmonary bypass operation. They are used as blood buffer in the extracorporeal circuit and as collecting and defoaming device for sucked blood. The vacuum-tight version of the VHK reservoir can also be employed postoperatively as drainage and auto-transfusion reservoir (e.g., for thorax drainage) to return the autologous blood to the patient which was removed from the thorax for the volume exchange.
Venous Hardshell Cardiotomy Reservoir, Adult, Vacuum-tight, with SOFTLINE Coatin
Venous Hardshell Cardiotomy Reservoir, Adult, Vacuum-tight, with SOFTLINE Coating, without screw connector, Sterile. The Venous Hardshell Cardiotomy Reservoirs are developed for the use in the field cardiopulmonary bypass operation. They are used as blood buffer in the extracorporeal circuit and as collecting and defoaming device for sucked blood. The vacuum-tight version of the VHK reservoir (VHK 71000) can also be employed postoperatively as drainage and auto-transfusion reservoir (e.g., for thorax drainage) to return the autologous blood to the patient which was removed from the thorax for the volume exchange.
For use with the Aquadex System. The Aquadex System is indicated for: Continuous
For use with the Aquadex System. The Aquadex System is indicated for: Continuous ultrafiltration therapy for temporary (up to 8 hours) or extended (longer than 8 hours in patients who require hospitalization) use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. All treatments must be administered within an outpatient or inpatient clinical setting by a healthcare provider, under physician prescription, both of whom having received training in extracorporeal therapies.
For use with the Aquadex System. The Aquadex System is indicated for: Continuous
For use with the Aquadex System. The Aquadex System is indicated for: Continuous ultrafiltration therapy for temporary (up to 8 hours) or extended (longer than 8 hours in patients who require hospitalization) use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. All treatments must be administered within an outpatient or inpatient clinical setting by a healthcare provider, under physician prescription, both of whom having received training in extracorporeal therapies.
For use with the Aquadex System. The Aquadex System is indicated for: Continuous
For use with the Aquadex System. The Aquadex System is indicated for: Continuous ultrafiltration therapy for temporary (up to 8 hours) or extended (longer than 8 hours in patients who require hospitalization) use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. All treatments must be administered within an outpatient or inpatient clinical setting by a healthcare provider, under physician prescription, both of whom having received training in extracorporeal therapies.
The Aquadex SmartFlow System is indicated for: Continuous ultrafiltration therap
The Aquadex SmartFlow System is indicated for: Continuous ultrafiltration therapy for temporary (up to 8 hours) or extended (longer than 8 hours in patients who require hospitalization) use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. All treatments must be administered within an outpatient or inpatient clinical setting by a healthcare provider, under physician prescription, both of whom having received training in extracorporeal therapies.
The Aquadex System is indicated for temporary (up to 8 hours) ultrafiltration tr
The Aquadex System is indicated for temporary (up to 8 hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended (longer than 8 hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization.
The Aquadex System is indicated for temporary (up to 8 hours) ultrafiltration tr
The Aquadex System is indicated for temporary (up to 8 hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended (longer than 8 hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization.
The Aquadex System is indicated for temporary (up to 8 hours) ultrafiltration tr
The Aquadex System is indicated for temporary (up to 8 hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended (longer than 8 hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization.